Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of the DRI II and LZI I fentanyl immunoassays for in vitro clinical diagnostic use

View through CrossRef
Abstract Introduction Fentanyl, a highly potent synthetic opioid, has contributed to a rapid rise in opioid-related overdoses and fatalities nationwide. Consequently, the need for accurate and timely testing for fentanyl has become critical. Immunoassay screens, reported as presumptive positive or negative, help address this need. We sought to compare the clinical performance of 2 US Food and Drug Administration (FDA)–approved fentanyl immunoassays—the Thermo Scientific DRI Fentanyl II Drugs of Abuse Assay and the Lin-Zhi International LZI Fentanyl (Q) Enzyme Immunoassay—for detection of fentanyl and its metabolites in urine, using liquid chromatography–tandem mass spectrometry (LC-MS/MS) as the reference method. Methods A total of 806 urine specimens were screened using 2 FDA-approved fentanyl immunoassays on Beckman Coulter DxC 700 AU Chemistry Analyzer. Of these specimens, 183 that were both positive and negative by immunoassay were further analyzed by LC-MS/MS for the presence or absence of fentanyl, norfentanyl, and 4-anilino-N-phenethylpiperidine (4-ANPP). Results Of the 806 specimens, 786 (98%) provided concordant results and 20 (2%) had discordant results between the 2 immunoassays. Concordance between immunoassays and LC-MS/MS was 97% for the LZI assay and 89% for the DRI assay. Among the 183 specimens tested, 4-ANPP was detected in 13 (7%). Discussion The 2 assays demonstrated comparable clinical utility for incorporation into a urine drug screen panel.
Title: Comparison of the DRI II and LZI I fentanyl immunoassays for in vitro clinical diagnostic use
Description:
Abstract Introduction Fentanyl, a highly potent synthetic opioid, has contributed to a rapid rise in opioid-related overdoses and fatalities nationwide.
Consequently, the need for accurate and timely testing for fentanyl has become critical.
Immunoassay screens, reported as presumptive positive or negative, help address this need.
We sought to compare the clinical performance of 2 US Food and Drug Administration (FDA)–approved fentanyl immunoassays—the Thermo Scientific DRI Fentanyl II Drugs of Abuse Assay and the Lin-Zhi International LZI Fentanyl (Q) Enzyme Immunoassay—for detection of fentanyl and its metabolites in urine, using liquid chromatography–tandem mass spectrometry (LC-MS/MS) as the reference method.
Methods A total of 806 urine specimens were screened using 2 FDA-approved fentanyl immunoassays on Beckman Coulter DxC 700 AU Chemistry Analyzer.
Of these specimens, 183 that were both positive and negative by immunoassay were further analyzed by LC-MS/MS for the presence or absence of fentanyl, norfentanyl, and 4-anilino-N-phenethylpiperidine (4-ANPP).
Results Of the 806 specimens, 786 (98%) provided concordant results and 20 (2%) had discordant results between the 2 immunoassays.
Concordance between immunoassays and LC-MS/MS was 97% for the LZI assay and 89% for the DRI assay.
Among the 183 specimens tested, 4-ANPP was detected in 13 (7%).
Discussion The 2 assays demonstrated comparable clinical utility for incorporation into a urine drug screen panel.

Related Results

Effect of Labor Epidural Analgesia with and without Fentanyl on Infant Breast-feeding
Effect of Labor Epidural Analgesia with and without Fentanyl on Infant Breast-feeding
Background The influence of labor epidural fentanyl on the neonate is controversial. The purpose of this study was to determine whether epidural fentanyl has an impact ...
Neuroinflammation and Neurometabolomic Profiling in Fentanyl Overdose Mouse Model Treated with Novel β-Lactam, MC-100093, and Ceftriaxone
Neuroinflammation and Neurometabolomic Profiling in Fentanyl Overdose Mouse Model Treated with Novel β-Lactam, MC-100093, and Ceftriaxone
Opioid-related deaths are attributed to overdoses, and fentanyl overdose has been on the rise in many parts of the world, including the USA. Glutamate transporter 1 (GLT-1) has bee...
Mesolimbic and mesocortical pathways differentially support fentanyl-context associations
Mesolimbic and mesocortical pathways differentially support fentanyl-context associations
Abstract Rationale Synthetic opioids like fentanyl are contributing to unprecedented overdose rates, yet the neural circuitry u...
Structural characterization of the RH1-LZI tandem of JIP3/4 highlights RH1 domains as a cytoskeletal motor-binding motif
Structural characterization of the RH1-LZI tandem of JIP3/4 highlights RH1 domains as a cytoskeletal motor-binding motif
AbstractJIP3 and JIP4 (JNK-interacting proteins 3 and 4) are adaptors for cargo recruitment by dynein/dynactin and kinesin1 motors. Both are dimers that are stabilised by two secti...
Fentanyl depression of respiration: comparison with heroin and morphine
Fentanyl depression of respiration: comparison with heroin and morphine
ABSTRACT Background and Purpose Fentanyl overdose deaths have reached ‘epidemic’ levels in North America. Death in opioid overd...
Opioid antagonism in fentanyl antinociception experimental
Opioid antagonism in fentanyl antinociception experimental
Among the most commonly used drugs to reduce pain and inflammation are nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids. Opioids are a wide group of drugs including fentan...

Back to Top